Literature DB >> 32198187

Self-control of vitamin K2 production captured in the crystal.

Mickaël Blaise1, Laurent Kremer2,3.   

Abstract

Menaquinone (MK) or vitamin K2 is an important metabolite that controls the redox/energy status of Mycobacterium tuberculosis Although the major steps of MK biosynthesis have been delineated, the regulatory mechanisms of this pathway have not been adequately explored. Bashiri et al. now demonstrate that MenD, catalyzing the first committed step of MK production, is allosterically inhibited by a downstream cytosolic metabolite in the MK biosynthesis pathway.
© 2020 Blaise and Kremer.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32198187      PMCID: PMC7086030          DOI: 10.1074/jbc.H120.013113

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Drug sensitivity and environmental adaptation of mycobacterial cell wall components.

Authors:  C E Barry; K Mdluli
Journal:  Trends Microbiol       Date:  1996-07       Impact factor: 17.079

2.  Allosteric regulation of menaquinone (vitamin K2) biosynthesis in the human pathogen Mycobacterium tuberculosis.

Authors:  Ghader Bashiri; Laura V Nigon; Ehab N M Jirgis; Ngoc Anh Thu Ho; Tamsyn Stanborough; Stephanie S Dawes; Edward N Baker; Esther M M Bulloch; Jodie M Johnston
Journal:  J Biol Chem       Date:  2020-02-06       Impact factor: 5.157

3.  Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study.

Authors:  Keertan Dheda; Jason D Limberis; Elize Pietersen; Jody Phelan; Aliasgar Esmail; Maia Lesosky; Kevin P Fennelly; Julian Te Riele; Barbara Mastrapa; Elizabeth M Streicher; Tania Dolby; Abdallah M Abdallah; Fathia Ben-Rached; John Simpson; Liezel Smith; Tawanda Gumbo; Paul van Helden; Frederick A Sirgel; Ruth McNerney; Grant Theron; Arnab Pain; Taane G Clark; Robin M Warren
Journal:  Lancet Respir Med       Date:  2017-01-19       Impact factor: 30.700

4.  MenA is a promising drug target for developing novel lead molecules to combat Mycobacterium tuberculosis.

Authors:  Michio Kurosu; Dean C Crick
Journal:  Med Chem       Date:  2009-03       Impact factor: 2.745

5.  Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non-replicating persistence.

Authors:  Rakesh K Dhiman; Sebabrata Mahapatra; Richard A Slayden; Melissa E Boyne; Anne Lenaerts; Jerald C Hinshaw; Shiva K Angala; Delphi Chatterjee; Kallolmay Biswas; Prabagaran Narayanasamy; Michio Kurosu; Dean C Crick
Journal:  Mol Microbiol       Date:  2009-02-11       Impact factor: 3.501

6.  Structural Views along the Mycobacterium tuberculosis MenD Reaction Pathway Illuminate Key Aspects of Thiamin Diphosphate-Dependent Enzyme Mechanisms.

Authors:  Ehab N M Jirgis; Ghader Bashiri; Esther M M Bulloch; Jodie M Johnston; Edward N Baker
Journal:  Structure       Date:  2016-06-09       Impact factor: 5.006

7.  Partial Saturation of Menaquinone in Mycobacterium tuberculosis: Function and Essentiality of a Novel Reductase, MenJ.

Authors:  Ashutosh Upadhyay; Fabio L Fontes; Mercedes Gonzalez-Juarrero; Michael R McNeil; Debbie C Crans; Mary Jackson; Dean C Crick
Journal:  ACS Cent Sci       Date:  2015-08-12       Impact factor: 14.553

8.  A Novel Small-Molecule Inhibitor of the Mycobacterium tuberculosis Demethylmenaquinone Methyltransferase MenG Is Bactericidal to Both Growing and Nutritionally Deprived Persister Cells.

Authors:  Paridhi Sukheja; Pradeep Kumar; Nisha Mittal; Shao-Gang Li; Eric Singleton; Riccardo Russo; Alexander L Perryman; Riju Shrestha; Divya Awasthi; Seema Husain; Patricia Soteropoulos; Roman Brukh; Nancy Connell; Joel S Freundlich; David Alland
Journal:  MBio       Date:  2017-02-14       Impact factor: 7.867

9.  Characterization of MenA (isoprenyl diphosphate:1,4-dihydroxy-2-naphthoate isoprenyltransferase) from Mycobacterium tuberculosis.

Authors:  Rakesh K Dhiman; Venugopal Pujari; James M Kincaid; Melanie A Ikeh; Tanya Parish; Dean C Crick
Journal:  PLoS One       Date:  2019-04-12       Impact factor: 3.240

10.  Novel MenA Inhibitors Are Bactericidal against Mycobacterium tuberculosis and Synergize with Electron Transport Chain Inhibitors.

Authors:  Bryan J Berube; Dara Russell; Lina Castro; Seoung-Ryoung Choi; Prabagaran Narayanasamy; Tanya Parish
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.